ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 890 filers reported holding ISHARES TR in Q4 2022. The put-call ratio across all filers is 1.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $354,886 | -5.0% | 2,902 | -1.4% | 0.03% | 0.0% |
| Q2 2023 | $373,516 | -0.3% | 2,942 | +1.4% | 0.03% | -5.6% |
| Q1 2023 | $374,822 | +103156.7% | 2,902 | +5.1% | 0.04% | 0.0% |
| Q4 2022 | $363 | -99.9% | 2,762 | -0.9% | 0.04% | 0.0% |
| Q3 2022 | $326,000 | +0.9% | 2,787 | +1.6% | 0.04% | +9.1% |
| Q2 2022 | $323,000 | -9.5% | 2,742 | +0.2% | 0.03% | +6.5% |
| Q1 2022 | $357,000 | -12.7% | 2,737 | +2.1% | 0.03% | -11.4% |
| Q4 2021 | $409,000 | -5.5% | 2,680 | 0.0% | 0.04% | -12.5% |
| Q3 2021 | $433,000 | -1.4% | 2,680 | 0.0% | 0.04% | 0.0% |
| Q2 2021 | $439,000 | +9.8% | 2,680 | +0.9% | 0.04% | +2.6% |
| Q1 2021 | $400,000 | -0.5% | 2,655 | 0.0% | 0.04% | -4.9% |
| Q4 2020 | $402,000 | +11.7% | 2,655 | 0.0% | 0.04% | 0.0% |
| Q3 2020 | $360,000 | -0.8% | 2,655 | 0.0% | 0.04% | -8.9% |
| Q2 2020 | $363,000 | +19.4% | 2,655 | -6.1% | 0.04% | +2.3% |
| Q1 2020 | $304,000 | -10.9% | 2,826 | 0.0% | 0.04% | +10.0% |
| Q4 2019 | $341,000 | – | 2,826 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Elliott Investment Management L.P. | 4,617,600 | $564,686,304 | 4.37% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 57,250 | $7,001,103 | 4.35% |
| DAFNA Capital Management LLC | 102,500 | $12,534,725 | 3.90% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,306,775 | 3.58% |
| Rye Brook Capital LLC | 40,900 | $5,002 | 3.56% |
| Bronte Capital Management Pty Ltd. | 283,229 | $34,636,074 | 3.49% |
| FWL INVESTMENT MANAGEMENT, LLC | 39,504 | $4,830,944 | 3.24% |
| Alpha Family Trust | 34,568 | $4,227,321 | 3.22% |
| HARBOUR INVESTMENT MANAGEMENT LLC | 40,720 | $4,985,830 | 2.85% |
| CUMBERLAND ADVISORS INC | 51,490 | $6,296,712 | 2.79% |